Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.01970
European Journal of Endocrinology, Vol 153, Issue 2, 239-248
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fahlbusch, R.
Right arrow Articles by Nimsky, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fahlbusch, R.
Right arrow Articles by Nimsky, C.

CLINICAL STUDY

Transsphenoidal surgery in acromegaly investigated by intraoperative high-field magnetic resonance imaging

Rudolf Fahlbusch, Boris v Keller, Oliver Ganslandt, Jürgen Kreutzer and Christopher Nimsky

Department of Neurosurgery, University Erlangen-Nürnberg, Schwabachanlage 6, 91 054 Erlangen, Germany

(Correspondence should be addressed to C Nimsky; Email: nimsky{at}nch.imed.uni-erlangen.de)

Objective: The aim of the study was to evaluate the effect of intraoperative high-field (1.5 Tesla) magnetic resonance imaging (MRI) on the results of transsphenoidal surgery of GH-secreting pituitary macroadenomas.

Methods: Twenty-three acromegalic patients (mean tumor size, 25 ± 12 mm; untreated preoperative GH, 4.2–159 µg/l; IGF-I, 349–1111 µg/l) were investigated by intraoperative high-field MRI. If intraoperative imaging depicted an accessible tumor remnant, resection was continued.

Results: In five patients intraoperative MRI led to further tumor removal, two of these met the consensus criteria for endocrine remission after 3 months. In two patients basal GH and oral glucose tolerance test (OGTT) were <2 µg/l, only IGF-I was slightly elevated, and in one patient GH was <5 µg/l and OGTT was 2 µg/l, with elevated IGF-I. Final intraoperative MRI showed no tumor remnants in 14 patients; eight of them met the consensus criteria for remission of acromegaly. In the patients with MRI showing incomplete removal (four suspect findings and five patients with intended partial removal) none was normalized.

Conclusion: With regard to the patients with a tumor configuration in whom complete tumor removal was considered (n = 18), intraoperative MRI increased the rate of endocrine normalization from 33 to 44% applying the consensus criteria, and improved endocrine outcome to ‘nearly normalization’ in another 17%. With regard to preoperative GH levels and tumor size, intraoperative MRI can help to achieve endocrine remission in patients who are normally considered not to be curable. However, taking GH as the tumor marker, even intraoperative high-field MRI was not able to detect tumor remnants in every case.




This article has been cited by other articles:


Home page
Am. J. Neuroradiol.Home page
S. Ulmer, E. Schulz, B. Moeller, U.R. Krause, A. Nabavi, H.M. Mehdorn, and O. Jansen
Radiation Dose of the Lens in Trans-sphenoidal Pituitary Surgery: Pros and Cons of a Conventional Setup Using Fluoroscopic Guidance and CT-Based Neuronavigation
AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1559 - 1564.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Melmed
Acromegaly
N. Engl. J. Med., December 14, 2006; 355(24): 2558 - 2573.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.